iVis Technologies received the CE Certification for the commercialization of SafeCross medical device

iVis Technologies received the CE Certification for the commercialization of SafeCross medical device

We are pleased to inform you that, on the 21st of February  2020, iVis Technologies received the CE Certification (awarded in compliance with the MDD 93/42/EEC European directive) for the commercialization of SafeCross™ medical device.

SafeCross™ is an innovative riboflavin ophthalmic solution, specifically designed for corneal cross-linking in thin corneas, to treat ectatic diseases  with the iVis Technologies’ proprietary combined technique of customized transepithelial laser corneal remodeling and crosslinking.

safecross
SafeCross logo